Cancer has been a leading cause of death worldwide for decades, accounting for nearly one in every six deaths and posing a serious threat to people’s health. A great number of plans an… Read More
NEW YORK, United States, 2023-Oct-16 — /EPR Network/ — “According to the research report published by Polaris Market Research, the Global Cancer Immunotherapy Market Size [… Read More
Cancer immunotherapy holds enormous potential in combating malignant tumors. Messenger ribonucleic acid (mRNA) has emerged as a widely studied tool in recent years, functioning within the cy… Read More
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete… Read More
MADRID — Immunotherapy, chemotherapy, and a PARP inhibitor in the first line improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, acc… Read More
- - - • The UMBRELLA Trial will investigate the clinical utility of escalating immunotherapy for cancer patients with molecular residual disease after completion of standard… Read More
In a medical first, scientists have hindered the growth of bowel cancers in mice by harnessing immune cells in the large intestine. One of the most exciting new cancer treatments is immunoth… Read More
Groundbreaking developments in the biotechnology sector are bringing hope to global health. This development centers on an innovative approach to immunotherapy using gamma delta T cells, a s… Read More